e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?
C. Arnold Spek, JanWillem Duitman
Source:
Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020
Journal Issue:
June
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Arnold Spek, JanWillem Duitman. Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?. Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Idiopathic pulmonary fibrosis: current challenges and future perspectives
Source: Eur Respir Rev 2013; 22: 103-105
Year: 2013
What have we learned from basic science studies on idiopathic pulmonary fibrosis?
Source: Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019
Year: 2019
Idiopathic pulmonary fibrosis: present understanding and future options
Source: Eur Respir Rev 2011; 20: 132-133
Year: 2011
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015
Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences
Source: Eur Respir Rev 2015; 24: 420-427
Year: 2015
Idiopathic pulmonary fibrosis trials: recommendations for the jury
Source: Eur Respir J 2011; 38: 1002-1004
Year: 2011
Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies
Source: Eur Respir J, 52 (3) 1801485; 10.1183/13993003.01485-2018
Year: 2018
Idiopathic pulmonary fibrosis: recent milestones in disease management
Source: Eur Respir Rev 2012; 21: 140
Year: 2012
Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012
Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Source: Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018
Year: 2019
Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice
Source: Eur Respir Rev, 26 (146) 170094; 10.1183/16000617.0094-2017
Year: 2017
Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017
Year: 2017
Imaging of idiopathic pulmonary fibrosis based on case presentations: guidelines, pitfalls and prevention of misdiagnosis
Source: Virtual Congress 2021 – Imaging grand round
Year: 2021
Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science
Source: Eur Respir J 2016; 47:1615-1617
Year: 2016
Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
Source: Eur Respir Rev 2014; 23:193-214
Year: 2014
The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF
Source: Eur Respir J 2015; 46: 883-886
Year: 2015
Idiopathic pulmonary fibrosis: classification, epidemiology, course and prognosis
Source: International Congress 2016 – Russia Session
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept